Portland Investment Counsel Inc. Bridge Bio Pharma, Inc. Transaction History
Portland Investment Counsel Inc.
- $248 Million
- Q3 2024
A detailed history of Portland Investment Counsel Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Portland Investment Counsel Inc. holds 15,000 shares of BBIO stock, worth $345,600. This represents 0.15% of its overall portfolio holdings.
Number of Shares
15,000
Previous 15,000
-0.0%
Holding current value
$345,600
Previous $379,000
0.53%
% of portfolio
0.15%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
291Shares Held
171MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$582 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$579 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$327 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$287 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$140 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.42B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...